PHARMA & LIFE SCIENCES: LATEST INTERVIEWS MORE INTERVIEWS

"As we get into precision medicines, therapies, parallel trials, and getting medicines to patients faster, that will require CDMOs to work together, and this is where our growth will come from."
"Etihad Cargo’s PharmaLife product has exponentially grown over the past year, and growth will trigger more physical ties between US and UAE."
“We are happy to report that we have initiated the Phase 2 SPAN adrulipase clinical and are currently screening patients for the study. We anticipate topline data by mid-2023.”
"In 2022, Massachusetts received 25% of all biopharma VC funding in the US. We are seeing new clusters emerge outside the traditional hubs of Kendall Square and Boston."

PHARMA & LIFE SCIENCES: LATEST ARTICLES

Funding Environment: Life Sciences Enter the Mainstream

April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.

Turkey Pharmaceuticals: Bringing All Actors Together

June 17, 2020
Industry, university, investors - the two-way bridge to the knowledge gap.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

Mexico Chemicals 2023 Chemical Week Release

Over the first 10 months of 2022, Mexico exported 20% more products to the United States than it did during the same period the year before. The global trend towards regionalization is lifting the entire Mexican industrial sector, but for the chemical industry in particular, 2022 was a year of nearshoring-driven growth. 

PARTNER EVENTS